Nanoparticle-Based Drug Delivery

Nanoparticle-based drug delivery involves engineering tiny particles—typically between 1 and 100 nanometers—to carry therapeutic compounds through the body and release them at specific sites, most notably within tumors. Because conventional chemotherapy distributes drugs indiscriminately, healthy tissue absorbs significant toxic burden alongside the intended target, and nanocarriers offer a way to concentrate treatment where it is needed while reducing systemic side effects. Researchers are actively refining how particle surfaces are chemically modified to improve circulation time, evade immune clearance, and recognize molecular markers on cancer cells, while magnetic nanoparticles add the possibility of guiding delivery externally using applied fields. Central open questions include how reliably the enhanced permeability and retention effect—a phenomenon where leaky tumor vasculature allows nanoparticles to accumulate—translates from animal models to human patients, and how manufacturing can be scaled without losing the precise size and surface properties that make these systems effective.

Works

88,860

Total citations

2,820,080

Keywords

NanocarriersDrug DeliveryNanoparticlesCancer TherapySurface EngineeringMagnetic Nanoparticles